LIVERS INC. Statement of Cash Flows For the Year Ended December 31, 20Y3 Cash fl

Question

LIVERS INC. Statement of Cash Flows For the Year Ended December 31, 20Y3 Cash flows from operating activities: Net income    Adjustments to reconcile net income to net cash flow from operating activities: Depreciation    Loss on inventory write down and fixed assets Gain on sale of investments    Changes in current operating assets and liabilities: Increase in accounts receivable    Increase in inventories    Increase in accounts payable    Decrease in accrued expenses payable    Net cash flow from operating activities    Cash flows from investing activities: Cash received from sale of investments    Cash paid for purchase of land    Cash paid for purchase of equipment    Net cash flow used for investing activities    Cash flows from financing activities: Cash received from sale of common stock    Cash paid for dividends    Net cash flow from financing activities    Change in cash    Cash at the beginning of the year    Cash at the end of the year    Optional: LIVERS INC. Spreadsheet (Work Sheet) for Statement of Cash Flows For the Year Ended December 31, 20Y3 Balance, Transactions Balance, Dec. 31, 20Y2 Debit Credit Dec. 31, 20Y3 Cash 150,000 155,000 Accounts receivable (net) 400,000 450,000 Inventories 750,000 770,000 Investments 100,000 - Land - - 500,000 Equipment 1,200,000 1,400,000 Accum. depr. - equipment (500,000) (600,000) Accounts payable (300,000) (340,000) Accrued expenses payable (50,000) (45,000) Dividends payable (25,000) (30,000) Common stock, $4 par (600,000) (700,000) Paid-in capital in excess of par (175,000) (200,000) Retained earnings (950,000) (1,360,000) Totals - - Operating activities: Net income Depreciation Gain on sale of investments Increase in accounts receivable Increase in inventories Increase in accounts payable Decrease in accrued expenses payable Investing activities: Purchase of equipment Purchase of land Sale of investments Financing activities: Declaration of cash dividends Sale of common stock Increase in dividends payable Net change in cash Totals LIVERS INC. Statement of Cash Flows For the Year Ended December 31, 20Y3 Cash flows from operating activities: Net income    Adjustments to reconcile net income to net cash flow from operating activities: Depreciation    Loss on inventory write down and fixed assets Gain on sale of investments    Changes in current operating assets and liabilities: Increase in accounts receivable    Increase in inventories    Increase in accounts payable    Decrease in accrued expenses payable    Net cash flow from operating activities    Cash flows from investing activities: Cash received from sale of investments    Cash paid for purchase of land    Cash paid for purchase of equipment    Net cash flow used for investing activities    Cash flows from financing activities: Cash received from sale of common stock    Cash paid for dividends    Net cash flow from financing activities    Change in cash    Cash at the beginning of the year    Cash at the end of the year    Optional: LIVERS INC. Spreadsheet (Work Sheet) for Statement of Cash Flows For the Year Ended December 31, 20Y3 Balance, Transactions Balance, Dec. 31, 20Y2 Debit Credit Dec. 31, 20Y3 Cash 150,000 155,000 Accounts receivable (net) 400,000 450,000 Inventories 750,000 770,000 Investments 100,000 - Land - - 500,000 Equipment 1,200,000 1,400,000 Accum. depr. - equipment (500,000) (600,000) Accounts payable (300,000) (340,000) Accrued expenses payable (50,000) (45,000) Dividends payable (25,000) (30,000) Common stock, $4 par (600,000) (700,000) Paid-in capital in excess of par (175,000) (200,000) Retained earnings (950,000) (1,360,000) Totals - - Operating activities: Net income Depreciation Gain on sale of investments Increase in accounts receivable Increase in inventories Increase in accounts payable Decrease in accrued expenses payable Investing activities: Purchase of equipment Purchase of land Sale of investments Financing activities: Declaration of cash dividends Sale of common stock Increase in dividends payable Net change in cash Totals

Explanation / Answer

Statement of Cash Flow Particulars Amount Total Amount Income = 410000+30000             440,000.00 Depreciation             100,000.00 Increase in AR             (50,000.00) Increase in inventory             (20,000.00) Increase in AP                40,000.00 Decrease in accrued expenses payable                (5,000.00) Cash flow from operating activities           505,000.00 Cash flow from Investing activities Sale of invt             100,000.00 Purchase of Land           (500,000.00) Sale of PPE           (200,000.00) Cash flow from Investing activities         (600,000.00) Cash flow from Financing activities Issue of Stock             100,000.00 Issue of additional Paid in capital                25,000.00 Dividends Paid             (25,000.00) Cash flow from Financing activities           100,000.00 net change in cash and cash equivalents                5,000.00 Opening cash and cash equivalents           150,000.00 Closing cash and cash equivalents           155,000.00

Related Questions

Navigate

• Browse (All)
• Browse L
• Subjects

---

---

Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.